Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types

• Published in: PloS one Vol. 9; no. 5; p. e97232
• Main Authors: Kwak, Kihyuck, Jiang, Rosie, Wang, Joshua W., Jagu, Subhashini, Kirnbauer, Reinhard, Roden, Richard B. S.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 09.05.2014; Public Library of Science (PLoS)
• Subjects: Alphapapillomavirus - genetics; Alphapapillomavirus - immunology; Alphapapillomavirus - pathogenicity; Alzheimer's disease; Amyloid Precursor Protein Secretases - antagonists & inhibitors; Anti-infective agents; Antibodies; Anticoagulants; Antigenic determinants; Antigens, Viral - immunology; Antisera; Betapapillomavirus - genetics; Betapapillomavirus - immunology; Betapapillomavirus - pathogenicity; Biology and Life Sciences; Blotting, Western; Capsid protein; Capsid Proteins - immunology; Carrageenan; Carrageenan - pharmacology; Cell surface; Cervical cancer; Concatamers; Deoxyribonucleic acid; DNA; Electrophoresis, Polyacrylamide Gel; Epitopes; Furin; Furin - antagonists & inhibitors; Gene expression; Genomes; Health aspects; Health risks; HeLa Cells; Heparan sulfate; Heparin; Heparin - pharmacology; Human papillomavirus; Humans; Immune Sera - pharmacology; Immunity; Immunoglobulins; Infection; Infections; Infectivity; Inhibitors; Luciferase; Luciferases; Medicine and Health Sciences; Melanoma; Microbicides; Mucopolysaccharides; Mucosa; Neutralization Tests; Papillomavirus; Papillomavirus infections; Papillomavirus Infections - immunology; Papillomavirus Infections - prevention & control; Papillomavirus Vaccines - genetics; Papillomavirus Vaccines - therapeutic use; Pathology; Proteins; Proteolysis; Real-Time Polymerase Chain Reaction; Secretase; Skin; Skin cancer; Skin diseases; Statistics, Nonparametric; Tropism; Vaccination; Vaccines; Vagina; Virology; Virulence; Viruses; United States > US; Maryland; Baltimore Maryland
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0097232

The licensed human papillomavirus (HPV) vaccines elicit type-restricted immunity but do not target cutaneous HPV types of the beta genus that are associated with non-melanoma skin cancer in immune-compromised patients, and it is unclear if these diverse types share a common mechanism of infection. Residues 11-88 of minor capsid protein L2 contain cross-protective epitopes, and vaccination with concatamers of this region derived from as many as eight alpha HPV (L2 α11-88x8) is being developed as an alternative prophylactic vaccine with potentially broader efficacy. There is also interest in developing broadly protective topical microbicides, such as carrageenan or heparin that block HPV receptor interactions, or small molecule inhibitors of infection. Here we have examined several inhibitors of HPV infection and antisera to L2 α11-88x8 for their breadth of activity against infection by 34 HPV types from within both the alpha and beta families using pseudovirions (PsV) carrying a luciferase reporter as surrogates for native virus. We observed that both heparin and carrageenan prevented infection by mucosatropic HPV types, but surprisingly PsV of several epidermotropic alpha4 and beta HPV types exhibited increased infectivity especially at low inhibitor concentrations. Furin and γ-secretase inhibitors and L2 α11-88x8 antiserum blocked infection by all HPV PsV types tested. These findings suggest that the distinct tropism of mucosal and cutaneous HPV may reflect distinct cell surface receptor interactions, but a common uptake mechanism dependent upon furin and γ-secretase proteolytic activities. Carrageenan, which is being tested as a vaginal microbicide, broadly inhibited infection by the high-risk mucosatropic HPV PsV, but not most skin tropic alpha and beta HPV. Vaccination with an L2 multimer derived exclusively from alpha papillomavirus sequences induced antibodies that broadly neutralized PsV of all 34 HPVs from within both the alpha and beta families, suggesting each displays conserved L2 neutralizing epitopes.